Stockreport

Bellerophon net loss improves in Q2 [Seeking Alpha]

Bellerophon Therapeutics, Inc.  (BLPH) 
Last bellerophon therapeutics, inc. earnings: 4/6 10:23 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bellerophon.com
PDF Bellerophon Therapeutics ( BLPH ) Q2 results : Revenues: $0; R&D Expense: $4.7M (+17.5%); SG&A: $1.6M (+33.3%); Operating Loss: ($6.3M) (-21.2%); Net Loss: ($3.9 [Read more]